AnaptysBio (NASDAQ:ANAB) Stock Price Down 4.3% - Time to Sell? - MarketBeat
7 hours ago • Google News
AnaptysBio Inc (ANAB)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 554.15M
P/E Ratio
0.00
Revenue (TTM)
$ 123.16M
Volume
0
52W High
$ 39.12
52W Low
$ 12.21
Dividend Yield
0.00%
Beta
-0.18
Technicals
50-Day MA
22.8974
200-Day MA
19.9063
52 Week High
39.115
52 Week Low
12.21
About ANAB
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics.
Employees
136
Headquarters
San Diego, CA
CEO
Mr. Daniel R. Faga
Latest News
Attention All Manufacturers and Suppliers: Boeing, ANSI-ANAB, - openPR.com
17 hours ago • Google News
$ANAB stock is down 9% today. Here's what we see in our data. - Quiver Quantitative
3 days ago • Google News